Search
for
Sort by
Research 31–60 of 1000+
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Semaglutide and the Skin: An Overview of Current Evidence
- Allergens and Irritants
- Adverse cutaneous effects of psychotropic medications
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Dorsal Skin Reactions of Hairless Dogs to Topical Treatment with Corticosteroids
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- Acute liver damage due to <i>Serenoa repens</i>: a case report
- Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Mirtazapine-induced Gynecomastia: An Unknown Side Effect?
- Feline Non-Flea Induced Hypersensitivity Dermatitis
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment